Flagship explainer
What drives Serina Therapeutics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$19.2M | FY2025 |
| |
| Income before tax | −$19.2M | FY2025 |
|
| Operating income | −$24M | FY2025 |
|
| $130000 | FY2025 |
| |
| Ending assets | $7M | FY2025 |
|
| Beginning assets | $6.7M | FY2024 |
|
| −$37000 | FY2025 |
| |
| $641000 | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001708599-26-000016